State
of New York
|
1-10113
|
11-0853640
|
(State
of Other Jurisdiction
|
(Commission
File Number)
|
(I.R.S.
Employer
|
of
Incorporation)
|
|
Identification
Number)
|
Exhibit Number |
Description
|
99.1 | Press Release dated November 3, 2006 Announcing Financial Results for Third Quarter 2006 |
ACURA PHARMACEUTICALS, INC. | ||
|
|
|
By: | /s/ Peter A. Clemens | |
Peter A. Clemens |
||
Senior Vice President & Chief Financial Officer | ||
Date: November 3, 2006 |
Exhibit Number |
Description
|
99.1 | Press Release dated November 3, 2006 Announcing Financial Results for Third Quarter 2006 |
ACURA
PHARMACEUTICALS, INC.
|
|||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|||||||||||||
(in
thousands, except per share data)
|
|||||||||||||
(unaudited)
|
(unaudited)
|
||||||||||||
Nine
Months Ended
|
Three
Months Ended
|
||||||||||||
September
30
|
September
30
|
||||||||||||
2006
|
|
2005
|
|
2006
|
|
2005
|
|||||||
Operating
Costs
|
|||||||||||||
Research
and Development
|
$
|
4,174
|
$
|
2,527
|
$
|
1,630
|
$
|
845
|
|||||
Marketing,
General and Administrative
|
4,754
|
2,120
|
1,031
|
628
|
|||||||||
Loss
from Operations
|
(8,928
|
)
|
(4,647
|
)
|
(2,661
|
)
|
(1,473
|
)
|
|||||
Other
Income (Expense)
|
|||||||||||||
Interest
Expense
|
(800
|
)
|
(434
|
)
|
(305
|
)
|
(171
|
)
|
|||||
Interest
Income
|
14
|
30
|
4
|
6
|
|||||||||
(Loss)
Gain on Asset Disposals
|
(10
|
)
|
85
|
7
|
3
|
||||||||
Other
|
(142
|
)
|
1
|
(142
|
)
|
-
|
|||||||
Net
Loss
|
$
|
(9,866
|
)
|
$
|
(4,965
|
)
|
$
|
(3,097
|
)
|
$
|
(1,635
|
)
|
|
Basic
and Diluted Loss Per Common Share
|
$
|
(0.03
|
)
|
$
|
(0.22
|
)
|
$
|
(0.01
|
)
|
$
|
(0.07
|
)
|
|
Weighted
Average Number of Outstanding Common Shares
|
343,947
|
22,906
|
346,835
|
23,169
|
|||||||||
ACURA
PHARMACEUTICALS, INC.
|
|||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|||||||
(in
thousands)
|
|||||||
(unaudited)
|
|
(audited)
|
|
||||
|
|
At
September 30
|
|
At
December 31
|
|
||
|
|
2006
|
|
2005
|
|||
Current
Assets
|
$
|
470
|
$
|
444
|
|||
Property,
Plant and Equipment, Net
|
1,194
|
1,341
|
|||||
Other
Assets
|
7
|
7
|
|||||
Total
Assets
|
$
|
1,671
|
$
|
1,792
|
|||
Current
Liabilities
|
11,922
|
2,922
|
|||||
Long
Term Portion of Capital Lease Obligations and Note Payable
|
13
|
5,032
|
|||||
Stockholders'
Deficit
|
(10,264
|
)
|
(6,162
|
)
|
|||
Total
Liabilities and Stockholders' Deficit
|
$
|
1,671
|
$
|
1,792
|